ArticleClinicoEconomics and outcomes research : CEOR2023

Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.

Jean Lachaine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.